Pharmaceutical Industries Ltd.
Menu
Health Products
WCAG 2.0
Print

Taro-Lurasidone
« Back to list view

Product Information

  • DIN:
    02504499
  • Active Ingredients :
    lurasidone hydrochloride
  • Innovator Name:
    LATUDA ®
  • Category:
    Antipsychotic Agent
  • Dosage form:
    Tablet
  • Strength:
    20 mg
  • Route of Administration:
    Oral
  • Package size:
    30 Bottle
  • UPC Code:
    063691100992
  • Description :
    Taro-Lurasidone tablets are white to off-white, round (20 mg and 40 mg), white to off-white, capsule shaped (60 mg), pale green, oval (80 mg), or white to off-white, oval (120 mg) and identified with strength-specific one-sided debossing, “578” (20 mg), “684” (40 mg), “639” (60mg), “685” (80 mg), or “579” (120 mg).
  • Non-medicinal ingredients :
    Mannitol, pregelatinized starch, alginic acid, croscarmellose sodium, colloidal silicon dioxide, magnesium stearate, Opadry® (hypromellose, titanium dioxide, macrogol, carnauba wax); 80 mg tablet also contains: iron oxide yellow, FD&C blue #1, and ferrosoferic oxide.
Taro-Lurasidone

All brand names and trademarks referenced remain the property of their respective owners.

To view the available Product Monographs for Taro Pharmaceuticals Inc. and TaroPharma products please click here to access the Health Canada Drug Product Database and search by DIN or other listed criteria. You may also contact us to request the information.

For Provincial Formulary Status click here

Product Information

  • DIN:
    02504502
  • Active Ingredients :
    lurasidone hydrochloride
  • Innovator Name:
    LATUDA ®
  • Category:
    Antiepileptic Agent
  • Dosage form:
    Tablet
  • Strength:
    40 mg
  • Route of Administration:
    Oral
  • Package size:
    30 Bottle
  • UPC Code:
    063691101036
  • Description :
    Taro-Lurasidone tablets are white to off-white, round (20 mg and 40 mg), white to off-white, capsule shaped (60 mg), pale green, oval (80 mg), or white to off-white, oval (120 mg) and identified with strength-specific one-sided debossing, “578” (20 mg), “684” (40 mg), “639” (60mg), “685” (80 mg), or “579” (120 mg).
  • Non-medicinal ingredients :
    Mannitol, pregelatinized starch, alginic acid, croscarmellose sodium, colloidal silicon dioxide, magnesium stearate, Opadry® (hypromellose, titanium dioxide, macrogol, carnauba wax); 80 mg tablet also contains: iron oxide yellow, FD&C blue #1, and ferrosoferic oxide.
Taro-Lurasidone

All brand names and trademarks referenced remain the property of their respective owners.

To view the available Product Monographs for Taro Pharmaceuticals Inc. and TaroPharma products please click here to access the Health Canada Drug Product Database and search by DIN or other listed criteria. You may also contact us to request the information.

For Provincial Formulary Status click here

Product Information

  • DIN:
    02504510
  • Active Ingredients :
    lurasidone hydrochloride
  • Innovator Name:
    LATUDA ®
  • Category:
    Antiepileptic Agent
  • Dosage form:
    Tablet
  • Strength:
    60 mg
  • Route of Administration:
    Oral
  • Package size:
    30 Bottle
  • UPC Code:
    063691101074
  • Description :
    Taro-Lurasidone tablets are white to off-white, round (20 mg and 40 mg), white to off-white, capsule shaped (60 mg), pale green, oval (80 mg), or white to off-white, oval (120 mg) and identified with strength-specific one-sided debossing, “578” (20 mg), “684” (40 mg), “639” (60mg), “685” (80 mg), or “579” (120 mg).
  • Non-medicinal ingredients :
    Mannitol, pregelatinized starch, alginic acid, croscarmellose sodium, colloidal silicon dioxide, magnesium stearate, Opadry® (hypromellose, titanium dioxide, macrogol, carnauba wax); 80 mg tablet also contains: iron oxide yellow, FD&C blue #1, and ferrosoferic oxide.
Taro-Lurasidone

All brand names and trademarks referenced remain the property of their respective owners.

To view the available Product Monographs for Taro Pharmaceuticals Inc. and TaroPharma products please click here to access the Health Canada Drug Product Database and search by DIN or other listed criteria. You may also contact us to request the information.

For Provincial Formulary Status click here

Product Information

  • DIN:
    02504529
  • Active Ingredients :
    lurasidone hydrochloride
  • Innovator Name:
    LATUDA ®
  • Category:
    Antiepileptic Agent
  • Dosage form:
    Tablet
  • Strength:
    80 mg
  • Route of Administration:
    Oral
  • Package size:
    30 Bottle
  • UPC Code:
    063691101111
  • Description :
    Taro-Lurasidone tablets are white to off-white, round (20 mg and 40 mg), white to off-white, capsule shaped (60 mg), pale green, oval (80 mg), or white to off-white, oval (120 mg) and identified with strength-specific one-sided debossing, “578” (20 mg), “684” (40 mg), “639” (60mg), “685” (80 mg), or “579” (120 mg).
  • Non-medicinal ingredients :
    Mannitol, pregelatinized starch, alginic acid, croscarmellose sodium, colloidal silicon dioxide, magnesium stearate, Opadry® (hypromellose, titanium dioxide, macrogol, carnauba wax); 80 mg tablet also contains: iron oxide yellow, FD&C blue #1, and ferrosoferic oxide.
Taro-Lurasidone

All brand names and trademarks referenced remain the property of their respective owners.

To view the available Product Monographs for Taro Pharmaceuticals Inc. and TaroPharma products please click here to access the Health Canada Drug Product Database and search by DIN or other listed criteria. You may also contact us to request the information.

For Provincial Formulary Status click here

Product Information

  • DIN:
    02504537
  • Active Ingredients :
    lurasidone hydrochloride
  • Innovator Name:
    LATUDA ®
  • Category:
    Antiepileptic Agent
  • Dosage form:
    Tablet
  • Strength:
    120 mg
  • Route of Administration:
    Oral
  • Package size:
    30 Bottle
  • UPC Code:
    063691101159
  • Description :
    Taro-Lurasidone tablets are white to off-white, round (20 mg and 40 mg), white to off-white, capsule shaped (60 mg), pale green, oval (80 mg), or white to off-white, oval (120 mg) and identified with strength-specific one-sided debossing, “578” (20 mg), “684” (40 mg), “639” (60mg), “685” (80 mg), or “579” (120 mg).
  • Non-medicinal ingredients :
    Mannitol, pregelatinized starch, alginic acid, croscarmellose sodium, colloidal silicon dioxide, magnesium stearate, Opadry® (hypromellose, titanium dioxide, macrogol, carnauba wax); 80 mg tablet also contains: iron oxide yellow, FD&C blue #1, and ferrosoferic oxide.
Taro-Lurasidone

All brand names and trademarks referenced remain the property of their respective owners.

To view the available Product Monographs for Taro Pharmaceuticals Inc. and TaroPharma products please click here to access the Health Canada Drug Product Database and search by DIN or other listed criteria. You may also contact us to request the information.

For Provincial Formulary Status click here

Health Products
WCAG 2.0

Copyright © Taro Pharmaceutical Industries Ltd.

Privacy Statement | Terms of Use | Safe Harbor Statement